Clin2
NCT07629167Possibly a fitNot yet recruiting

Isotretinoin vs. Doxycycline for Cancer-Drug Rash

Acneiform Drug EruptionAcneiform Eruptions

Treatments studied

Part of Skin clinical trials.

This study compares two medicines—isotretinoin and doxycycline—to treat a specific type of skin rash that develops in people taking certain cancer drugs. The rash (called acneiform) looks like acne with bumps and pustules. The trial will help doctors figure out which treatment works better and is safer for younger patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
12 years to 39 years
Study type
Interventional

Who can take part

  • You must have developed a moderate-to-severe acne-like rash (with bumps and pustules covering at least 10% of your body) while taking a cancer drug that targets the MAPK pathway
  • You must be between 12 and 39 years old
  • You must have healthy liver function based on blood tests
  • If you can have children, you must use strong contraception (two forms if taking isotretinoin) and agree not to become pregnant during and for one month after the study
  • You must be able to swallow pills and take gelatin capsules
  • You must not be pregnant, breastfeeding, or have thoughts of harming yourself; you must also agree to be photographed for skin review

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07544251Recruiting· Phase 4
Sarecycline vs. Doxycycline for Acne and Gut Health

This study compares two antibiotic medications (sarecycline and doxycycline) to see which one works better for moderate acne while also being gentler on the bacteria in your gut. Researchers will track how your skin improves and how these drugs affect your digestive system.

Sacramento, California
NCT05942248Recruiting
Computer image grading for common face skin rashes

This study uses special computer measurements from facial photos to evaluate how acne, rosacea, melasma, or seborrheic dermatitis look. If you have one of these conditions, it may help researchers better track skin changes over time.

Sacramento, California
NCT06225570Recruiting· Early Phase 1
Weekly isotretinoin vs tetracycline for moderate acne

This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.

Charleston, South Carolina
NCT07639073Not yet recruiting· Phase 4
Low-dose vs standard-dose isotretinoin for moderate to severe acne

This study compares two different dosages of isotretinoin (a powerful acne medication) to see which works better and causes fewer side effects. Isotretinoin is typically used for acne that hasn't improved with other treatments.

Islamabad
NCT06447480Recruiting· Phase 3
Comparing isotretinoin to standard care for moderate acne in darker skin

This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.

Nice, Alpes-Maritimes
NCT07296523Enrolling by invitation
Expert views on isotretinoin for acne

This study gathers opinions from experienced dermatologists to create expert guidelines on using isotretinoin for acne. It does not test a new treatment but aims to improve how isotretinoin is prescribed.

Cairo

Hear when a new Acneiform Drug Eruption trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.